Press Release

Roy Proujansky, M.D., and Irving Nachamkin, DrPH, Join Rheonix Board

ITHACA, N.Y. — Rheonix Inc. today announced the appointment of Roy Proujansky, M.D., and Irving Nachamkin, DrPH, MPH, to its board of directors. "I'm honored to welcome Drs. Proujansky and Nachamkin to our board," said Greg Galvin, Ph.D., founder and CEO of Rheonix. "They join Rheonix at an exciting time as we provide critical testing solutions to address the pandemic and broaden our clinical diagnostic portfolio. The addition of these directors complements… Read More »

Rheonix COVID-19™ MDx Assay Receives Expanded FDA Emergency Use Authorization to Include Saliva as a Sample Type

ITHACA, N.Y. — Rheonix Inc. announced today that the United States Food and Drug Administration (FDA) has issued an expanded Emergency Use Authorization (EUA) for the Rheonix COVID-19™ MDx Assay and now allows the use of saliva as an approved sample type. The fully automated sample-to-answer assay was initially authorized for use on a range of respiratory specimens under EUA on April 29, 2020.   The ability to test saliva samples for the… Read More »

Rheonix Inc. Receives FDA Emergency Use Authorization for Rapid, Fully Automated Molecular COVID-19 Test

• Sample-to-answer method will enable rapid testing in distributed locations • Rheonix has begun shipments to laboratories under Emergency Use Authorization ITHACA, N.Y. — Rheonix Inc. announced today that it has received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA) for the Rheonix COVID-19TM MDx Assay. The fully automated test enables detection of SARS-CoV-2, the virus that causes COVID-19, directly from respiratory samples. The test is designed to operate on… Read More »

Rheonix Inc. to Launch Rapid, Fully Automated Coronavirus Disease 2019 (COVID-19) Assay

Assay to provide small and medium-sized labs access to fast, cost-effective, sample-to-answer testing for public health threat ITHACA, N.Y. — Rheonix Inc., a leader in highly automated molecular diagnostics, today announced it is developing a coronavirus (COVID-19) test kit for use on its Encompass MDx® workstation. Upon Rheonix’s receipt of emergency use authorization (EUA) from the Food and Drug Administration (FDA), the new test will allow for the fully automated detection… Read More »

Rheonix Inc. Files 510(k) Seeking FDA Clearance of Triplex Sexually Transmitted Infection Assay

ITHACA, N.Y. — Rheonix, Inc. Rheonix filed its first 510(k) on November 4, seeking to gain FDA clearance of its Rheonix STI TriPlex™ Assay (a PCR-based assay for the simultaneous detection for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis) as well as the Rheonix Encompass MDx® Workstation, a fully automated “sample-to-answer” system capable of taking untreated clinical specimens and extracting, purifying and PCR amplifying DNA targets.  In addition the 510(k) filing… Read More »

Rheonix Inc. and Mérieux NutriSciences Announce the Successful Conclusion of Early-Access Listeria PatternAlert™ Assay Evaluation

Method Enables Food Producers to Rapidly Identify and Address Recurring Listeria in Facilities ITHACA, N.Y. — Rheonix Inc. and Mérieux NutriSciences announce the successful conclusion of early-access customer evaluations of the Listeria PatternAlert™ assay, a breakthrough method for rapidly identifying molecular patterns from Listeria strains. The method assists food producers in identifying harborage sites for persistent Listeria and in tracing back sources of contamination. Results are available at roughly half the cost… Read More »

Rheonix Announces Launch of NGS OnePrep™ Automated DNA Extraction and Library Preparation Solution

Company to present data on automated solution at Association of Molecular Pathology Annual Meeting and Corporate Workshop Oct. 31 ITHACA, N.Y. — Rheonix, Inc. announces the launch of its NGS OnePrep™ solution, an integrated, automated method for DNA extraction and next-generation sequencing (NGS) library preparation on the Encompass Optimum™ workstation, at the Association of Molecular Pathology (AMP) Annual Meeting and Expo Nov.1-3 in San Antonio, Texas. The method will allow laboratory technicians… Read More »

Rheonix announces breakthrough environmental monitoring technology with the Listeria PatternAlert™ assay

Automated method enables rapid identification of recurring Listeria patterns direct from enriched sample in six hours ITHACA, N.Y. — Rheonix Inc. announces the launch of its Listeria PatternAlert™ assay, a breakthrough method for rapidly identifying molecular patterns from Listeria strains. The method will assist food producers in identifying harborage sites for persistent Listeria and in tracing back sources of contamination. The Listeria PatternAlert assay provides results in just six hours after a… Read More »

Rheonix launches enhanced technology that detects more than 60 organisms responsible for beer spoilage, saving brewers time and reducing risk of beer recalls

Beer SpoilerAlert™ assay and Encompass Optimum™ workstation enable next-day detection of spoilage organisms and hop resistance genes for brewers ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, has expanded its Beer SpoilerAlert™ assay to detect more organisms that may cause spoilage in beer. The Beer SpoilerAlert assay now detects over 60 bacterial and yeast spoilage organisms plus four hop resistance genes, all in a single test, making… Read More »

Rheonix to Showcase Fully Automated Next Generation Sequencing Library Prep from Raw Samples at AACC Meeting

Company to showcase fully automated solution at AACC’s Emerging Clinical & Laboratory Diagnostics in the Healthcare Ecosystem meeting ITHACA, N.Y. — Rheonix Inc., a supplier of fully automated molecular testing solutions, will highlight its fully automated and integrated sample preparation solution on the Encompass Optimum™ workstation at the AACC’s Emerging Clinical & Laboratory Diagnostics in the Healthcare Ecosystem meeting Nov. 9 in San Diego, California. The workstation simplifies, integrates and automates… Read More »

Archives

Rheonix COVID-19™ MDx Assay Receives Expanded FDA Emergency Use Authorization to Include Saliva as a Sample Type.
Learn More